It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

In a lecture at VMX, Jason B. Pieper, DVM, MS, DACVD, outlined the next steps in the treatment of pyoderma in dogs when the ...

penelope.bryant{at}rch.org.au Objective Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat children at home, but studies in children are scarce. We aimed to describe the ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

One reason for not achieving better results in chronic bacteriuria, even after protracted antimicrobial therapy, may be failure to differentiate two patterns of recurrent infections – namely ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Jason B. Pieper, DVM, MS, DACVD, talked about pyoderma, including ingredients and formulations, in his lecture at the 2025 ...

potentially transforming the landscape of antimicrobial therapy. To gather further insights in this critical area of research, we welcome articles focusing on, but not limited to, the following themes ...

RA'ANANA, Israel - Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN), an innovative medical technology company valued at $15.7 million, has announced positive initial results from its collaboration ...

(Kate Summer) Overall, oyster hemolymph proteins hold promise for future development as an antimicrobial therapy. They can kill pathogens embedded in biofilms, work in synergy with conventional ...

The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the ...

In 2017, a tragic incident unfolded in a Nevada hospital. A woman, admitted for pneumonia, tragically succumbed to multiple ...